S&P 500

5.509,01

0,62%

Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Bellevue Life Sciences Acquisition Corporation (BLACU)
Bellevue Life Sciences Acquisition Corporation (BLACU) Notícias

BLACU

Bellevue Life Sciences A... (BLACU)

Bellevue Life Sciences Acquisition Corporation

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:BLACU

1

Data	Hora	Fonte	Título	Código	Companhia
21/02/2024	18:20	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BLACU	Bellevue Life Sciences Acquisition Corporation
08/02/2024	18:20	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:BLACU	Bellevue Life Sciences Acquisition Corporation
05/02/2024	15:48	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:BLACU	Bellevue Life Sciences Acquisition Corporation
16/11/2023	19:00	PR Newswire (US)	OSR Holdings Co., Ltd. Enters Into Business Combination Agreement with Bellevue Life Sciences Acquisition Corp.	NASDAQ:BLACU	Bellevue Life Sciences Acquisition Corporation
16/11/2023	18:37	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:BLACU	Bellevue Life Sciences Acquisition Corporation
07/11/2023	18:20	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:BLACU	Bellevue Life Sciences Acquisition Corporation
20/10/2023	17:20	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:BLACU	Bellevue Life Sciences Acquisition Corporation
10/10/2023	18:00	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:BLACU	Bellevue Life Sciences Acquisition Corporation
11/07/2023	17:45	PR Newswire (US)	Bellevue Life Sciences Acquisition Corp. and OSR Holdings Sign an Exclusive Letter of Intent for a Business Combination	NASDAQ:BLACU	Bellevue Life Sciences Acquisition Corporation
14/06/2023	18:01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:BLACU	Bellevue Life Sciences Acquisition Corporation
22/05/2023	17:35	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:BLACU	Bellevue Life Sciences Acquisition Corporation
16/05/2023	09:01	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	NASDAQ:BLACU	Bellevue Life Sciences Acquisition Corporation
31/03/2023	17:20	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:BLACU	Bellevue Life Sciences Acquisition Corporation
27/03/2023	17:10	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BLACU	Bellevue Life Sciences Acquisition Corporation
14/03/2023	17:05	PR Newswire (US)	Bellevue Life Sciences Acquisition Corp. Announces Separate Trading of its Shares of Common Stock, Warrants and Rights Commencing March 17, 2023	NASDAQ:BLACU	Bellevue Life Sciences Acquisition Corporation
21/02/2023	18:05	PR Newswire (US)	Bellevue Life Sciences Acquisition Corp. Announces Closing of Full Over-allotment Option	NASDAQ:BLACU	Bellevue Life Sciences Acquisition Corporation
14/02/2023	18:05	PR Newswire (US)	Bellevue Life Sciences Acquisition Corp. Announces Closing of $60 Million Initial Public Offering	NASDAQ:BLACU	Bellevue Life Sciences Acquisition Corporation